SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001493152-23-038049
Filing Date
2023-10-24
Accepted
2023-10-24 07:59:13
Documents
20
Period of Report
2023-10-24
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 3.02: Unregistered Sales of Equity Securities
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 55237
2 ex4-6.htm EX-4.6 161727
3 ex4-7.htm EX-4.7 111036
4 ex10-1.htm EX-10.1 351056
5 ex10-2.htm EX-10.2 115657
6 ex10-3.htm EX-10.3 88775
7 ex10-4.htm EX-10.4 231630
8 ex10-5.htm EX-10.5 36308
9 ex99-1.htm EX-99.1 16241
  Complete submission text file 0001493152-23-038049.txt   1576663

Data Files

Seq Description Document Type Size
10 INLINE XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT ensc-20231024.xsd EX-101.SCH 3012
11 INLINE XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT ensc-20231024_lab.xml EX-101.LAB 34240
12 INLINE XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT ensc-20231024_pre.xml EX-101.PRE 22357
14 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3431
Mailing Address 7946 IVANHOE AVENUE SUITE 201 LA JOLLA CA 92037
Business Address 7946 IVANHOE AVENUE SUITE 201 LA JOLLA CA 92037 (858) 263-4196
Ensysce Biosciences, Inc. (Filer) CIK: 0001716947 (see all company filings)

IRS No.: 822755287 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38306 | Film No.: 231341195
SIC: 2834 Pharmaceutical Preparations